Ece Özoğul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ece Özoğul has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Arzu Saglam
Department of Pathology, Hacettepe University Faculty of Medicine, Ankara, Turkey
2 shared publications - Aysegul Uner
Department of Pathology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
2 shared publications - Serkan Akın
Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
2 shared publications - Ahmet Erim Pamuk
Department of Otorhinolaryngology, Hacettepe University, Ankara, Turkey
1 shared publication - Aykut Özdoğan
Department of Otorhinolaryngology, Ankara Etlik City Hospital, Ankara, Turkey
1 shared publication - Ayşen Karaduman
Dermatology and Venereology Department, Faculty of Medicine Hacettepe University Ankara Turkey
1 shared publication
Latest Publications
- 11 September 2026
- Published by Springer Nature in Journal of Hematopathology
- Vol. 19 (1) , 54
Large B-cell lymphoma with IRF4 rearrangement: clinicopathologic heterogeneity across the age spectrum
- 11 September 2026
- Published by Springer Nature in Journal of Hematopathology
- Vol. 19 (1) , 54
Large B-cell lymphoma with IRF4 rearrangement: clinicopathologic heterogeneity across the age spectrum
- 3 August 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (11) , 7377-7386
Prognostic significance of GLUT-1 in adenoid cystic carcinoma
Purpose Adenoid cystic carcinoma (ACC) is a common malignant tumor of the salivary glands. However, it lacks established prognostic markers. This study investigates the prognostic relevance of glucose transporter-1 (GLUT-1) in ACC. Methods Seventy patients diagnosed with ACC were included in the study. Immunohistochemical analysis was performed to evaluate GLUT-1 expression levels by intensity, distribution, and scoring. These scores were correlated with clinicopathological parameters, overall survival (OS), and disease-free survival (DFS). The prognostic performance of GLUT-1 was assessed using ROC curve analysis and independent prognostic factors were identified through univariate and multivariate Cox regression models. Results The GLUT-1 expression rate was 98.5%. Higher GLUT-1 scores were linked to solid histological subtype (p < 0.001), advanced T-stage (p < 0.001), perineural invasion (p < 0.001), lymph node metastasis (p = 0.009), and distant metastasis (p < 0.001). A GLUT-1 score > 5 accurately predicted mortality (AUC 0.921, 81.5% sensitivity, 95.3% specificity; p < 0.001), according to ROC analysis. Univariate analysis identified several risk factors for OS. In the multivariable Cox regression model, only a GLUT-1 score > 5 remained independently associated with a 14.7-fold increase in mortality risk (HR: 14.795; p = 0.003). Conclusion Our findings demonstrate that GLUT-1 expression is an independent prognostic marker for overall survival in ACC. Unlike traditional staging systems, the GLUT-1 score provides superior accuracy in risk stratification. Incorporating GLUT-1 scoring into routine pathological evaluation may facilitate the identification of high-risk patients and guide more personalized therapeutic strategies.
- 3 August 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (11) , 7377-7386
Prognostic significance of GLUT-1 in adenoid cystic carcinoma
Purpose Adenoid cystic carcinoma (ACC) is a common malignant tumor of the salivary glands. However, it lacks established prognostic markers. This study investigates the prognostic relevance of glucose transporter-1 (GLUT-1) in ACC. Methods Seventy patients diagnosed with ACC were included in the study. Immunohistochemical analysis was performed to evaluate GLUT-1 expression levels by intensity, distribution, and scoring. These scores were correlated with clinicopathological parameters, overall survival (OS), and disease-free survival (DFS). The prognostic performance of GLUT-1 was assessed using ROC curve analysis and independent prognostic factors were identified through univariate and multivariate Cox regression models. Results The GLUT-1 expression rate was 98.5%. Higher GLUT-1 scores were linked to solid histological subtype (p < 0.001), advanced T-stage (p < 0.001), perineural invasion (p < 0.001), lymph node metastasis (p = 0.009), and distant metastasis (p < 0.001). A GLUT-1 score > 5 accurately predicted mortality (AUC 0.921, 81.5% sensitivity, 95.3% specificity; p < 0.001), according to ROC analysis. Univariate analysis identified several risk factors for OS. In the multivariable Cox regression model, only a GLUT-1 score > 5 remained independently associated with a 14.7-fold increase in mortality risk (HR: 14.795; p = 0.003). Conclusion Our findings demonstrate that GLUT-1 expression is an independent prognostic marker for overall survival in ACC. Unlike traditional staging systems, the GLUT-1 score provides superior accuracy in risk stratification. Incorporating GLUT-1 scoring into routine pathological evaluation may facilitate the identification of high-risk patients and guide more personalized therapeutic strategies.
- Open Access
- 13 June 2022
- Published by Hacettepe University - Medical School in Acta Medica
- Vol. 53 (4) , 398-400
Unusual Presentation of Follicular Lymphoma with the Involvement of Bilateral Ear Helices and Lobes
Follicular lymphoma is a type of systemic lymphomas which constitutes approximately 30-35% of all Non-Hodgkin lymphomas. It typically presents itself in the form of generalized lymphadenopathy, hepatomegaly, splenomegaly and bone marrow involvement. Cutaneous involvement of follicular lymphoma generally appears as skin-coloured to red, violaceous papules or nodules most commonly involving the scalp, trunk and head&neck region. Herein, we would like to present an unusual case of follicular lymphoma which appears as skin-coloured papules prominent upon the both ears and trunk.
- 13 June 2022
- Published by Hacettepe University - Medical School in Acta Medica
- Vol. 53 (4) , 398-400
Open AccessUnusual Presentation of Follicular Lymphoma with the Involvement of Bilateral Ear Helices and Lobes
Follicular lymphoma is a type of systemic lymphomas which constitutes approximately 30-35% of all Non-Hodgkin lymphomas. It typically presents itself in the form of generalized lymphadenopathy, hepatomegaly, splenomegaly and bone marrow involvement. Cutaneous involvement of follicular lymphoma generally appears as skin-coloured to red, violaceous papules or nodules most commonly involving the scalp, trunk and head&neck region. Herein, we would like to present an unusual case of follicular lymphoma which appears as skin-coloured papules prominent upon the both ears and trunk.
- Open Access
- 6 February 2019
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 36 (1) , 57-59
EBV-Related Diffuse Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma
- 6 February 2019
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 36 (1) , 57-59
Open AccessEBV-Related Diffuse Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma